BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Emerging research has provided fresh evidence regarding the role of viral infection in the development of multiple sclerosis.

Researchers at the University of Cincinnati are developing an immune-stimulating wafer to be used after brain tumour surgery, ...

There is a new hope for people with spinal cord injuries. Doctors are using an experimental, easy to deliver drug, with ...

Gabapentin is approved by the FDA for seizures and postherpetic neuralgia; gabapentin enacarbil is approved for restless legs ...

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...

Outdoor air pollution is a combination of dangerous chemicals and gases stemming from various sources, such as wildfires and volcanic activity, to traffic and factories. This causes harmful pollutants ...

Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

Allschwil, Switzerland - February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker ...

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like arthritis, IBD, allergies, and more.